PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell
09-May-2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee HUTCHMED
09-May-2024 ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator ENA Respiratory
09-May-2024 DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler DevPro Biopharma
08-May-2024 Free GCP Training from Pharma Lessons Pharma Lessons
07-May-2024 Jo Goodman Joins Celerion as Vice President of Bioanalytical Services Celerion
07-May-2024 PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments PureTech Health plc
07-May-2024 Leica Microsystems adds cutting-edge light sheet solutions to its portfolio with the integration of Viventis Microscopy Leica Microsystems
07-May-2024 TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of development TMC Pharma Services Ltd
07-May-2024 EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b EyeDNA Therapeutics
07-May-2024 National approval for MOB-015 in all 13 countries Moberg Pharma AB
07-May-2024 Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update Atopia Therapeutics
03-May-2024 SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab SynOx Therapeutics Limited
03-May-2024 NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA ANGLE plc
02-May-2024 Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation Site location, community reflective advertising, translation of study materials and social media outreach among the top methods Lindus Health
02-May-2024 ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024 The European Laboratory Research & Innovation Group (ELRIG) UK
01-May-2024 Revival Research Trio Are Raising Research Standards GCSA - The Global Quality Standard for Clinical Research Sites
01-May-2024 Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board Tessellate BIO
01-May-2024 Significant POLB 001 Patent Granted in United States Poolbeg Pharma plc